Myc protein overexpression is a feature of progression and adverse prognosis in multiple myeloma

0
0 / 5 (0 votos)

European Journal of Haematology

Fecha de publicación: 12 July 2018

DOI: https://doi.org/10.1111/ejh.13141

Autores: Hanne E. H. Møller, Birgitte S. Preiss, Per Pedersen, Brian Østergaard, Mikael Frederiksen, Niels Abildgaard, Michael B. Møller

Background: Prognostic and predictive markers in multiple myeloma are continuously explored because of the heterogeneity of the tumor biology. Myc protein is the final product from activating MYC oncogene, but the prognostic impact in multiple myeloma is not well described.

Seguir leyendo